Connecting Business to Transformation
Integrated solutions from market-leading specialists
Proactive success across the globe
A team purpose-built to meet your needsEvery Alira Health project team is hand-picked based on the specific requirements, needs, and goals of each project.
This allows us to effectively complement your expertise with a powerful combination of strategists, doctors, bankers and scientists from around the world.
Your dedicated team provides a complete continuum of support with a 360° approach that is tailored to your business and targeted for growth.
Working together to humanize healthcare
Whether you need to understand which asset best aligns with your long-term strategy, which new market or therapeutic area to explore, or how to expand into another sector, we are ready to help you lead the way.
Chief Commercial Officer, Executive Vice President of the Transaction Advisory
We integrate our M&A and Investment Banking expertise with in-depth market, medical, and science understanding to advise you every step of the way.
Alira Health Secures an Additional $40M in Funding, Led by Creadev
We announced today the closing of an equity financing in which it raised gross proceeds of US$40 million. We intend to use the funds to invest in solutions that actively engage patients(...)
What You Should Know Before Choosing a Healthcare Transaction Advisory Firm
What’s most important when selecting a firm for your next transaction? Global experience, staff profiles, technical expertise? To learn more read our latest TAD Infographic.
Alira Health Strengthens its Growth Strategy with a $35M Funding, led by Creadev
Alira Health strengthens its growth strategy with a $35M funding, led by Creadev.
We Announce our role as Strategic Advisor to Mérieux Equity Partners and Mérieux Participations 3 for Entering the Capital of CTRS
We are pleased to announce our role as strategic advisor to Mérieux Equity Partners as they join the Series A financing round of Cell-Easy, through Mérieux’s newly established venture fund, OMX.
We Announce our Role as Strategic Advisor to Benvic in the Acquisition of Luc & Bel
We are proud to announce our role as strategic advisor to Benvic in the acquisition of Luc & Bel.
Five Key Success Factors for Managing Transactions in Full Virtual Mode
It is no secret that the COVID-19 pandemic has presented new challenges for businesses, and virtual has become the ‘new normal’, including for transactions.
Q3 2020 Medical Device Contract Development and Manufacturing M&A Report
Despite the COVID-19 pandemic, M&A activity in the global CDMO industry has been exceptionally strong in 2020 with a record number of transactions completed during the third quarter alone.